Global Pharmaceuticals & Biotech Breakout Stocks

Arrowhead Pharmaceuticals

Market Cap: US$7.2b

Develops medicines for the treatment of intractable diseases in the United States.

Kolon TissueGene

Market Cap: ₩7.1t

Develops cell therapies for orthopedic diseases and other unmet medical needs.

Spyre Therapeutics

Market Cap: US$2.3b

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

Olema Pharmaceuticals

Market Cap: US$2.2b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Trevi Therapeutics

Market Cap: US$1.7b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

MBX Biosciences

Market Cap: US$1.5b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Savara

Market Cap: US$1.5b

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Nektar Therapeutics

Market Cap: US$1.3b

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Lin BioScience

Market Cap: NT$36.6b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

Curiox Biosystems

Market Cap: ₩1.6t

Manufactures and sells medical appliances and instruments in South Korea.

Frontier Biotechnologies

Market Cap: CN¥7.5b

A commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patients’ health in China.

Esperion Therapeutics

Market Cap: US$944.1m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

RAPT Therapeutics

Market Cap: US$936.6m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.

PKU HealthCareLtd

Market Cap: CN¥4.2b

Engages in the research and development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China.

Kolon Life Science

Market Cap: ₩760.3b

A biotechnology company, develops cell and gene therapy products.

Guangdong Lifestrong Pharmacy

Market Cap: CN¥3.7b

Engages in the research, development, production, and sale of pharmaceutical products.

Lyell Immunopharma

Market Cap: US$509.2m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Jiangsu Gdk Biological Technology

Market Cap: CN¥3.4b

Engages in the research, development, production, and sale of human vaccines.

Hubei Guangji Pharmaceutical

Market Cap: CN¥3.3b

Manufactures and sells pharmaceutical raw materials, medicinal feed additives, fine chemicals, and preparations in China.

AP Biosciences

Market Cap: NT$11.4b

Researches and develops protein and antibody drugs for unmet medical needs.

TriSalus Life Sciences

Market Cap: US$343.3m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.

NervGen Pharma

Market Cap: CA$416.0m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

3-D Matrix

Market Cap: JP¥42.3b

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally.

Burning Rock Biotech

Market Cap: US$232.5m

Develops and sells cancer therapy selection tests in the People's Republic of China and the United States.

HEM Pharma

Market Cap: ₩330.8b

Operates as a microbiome healthcare company in South Korea and internationally.

Quince Therapeutics

Market Cap: US$203.2m

A biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.

Immuno-Biological Laboratories

Market Cap: JP¥29.1b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

Thor Medical

Market Cap: NOK 1.6b

Produces and supplies alpha-particle emitters for cancer therapy in Norway.

Surrozen

Market Cap: US$142.1m

A biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair.

RaQualia Pharma

Market Cap: JP¥22.1b

Engages in the research and development of pharmaceutical compounds worldwide.

Shield Therapeutics

Market Cap: UK£105.1m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Gain Therapeutics

Market Cap: US$126.8m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

Ovid Therapeutics

Market Cap: US$126.8m

A biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States.

Cantargia

Market Cap: SEK 1.0b

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

Captor Therapeutics Spolka Akcyjna

Market Cap: zł363.8m

A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.

ViGenCell

Market Cap: ₩125.6b

Specializes in immune cell therapy.